A atividade do British Council na area de aperfeiçoamento educacional no que se refere a treinamento de brasileiros na Grã-Bretanha e subsequente avaliação de resultados: um estudo de caso

Esta pesquisa tem por objetivo examinar as atividades do British Council no que concerne ao intercâmbio cultural de brasileiros, como também, verificar os resultados dos programas de treinamento realizados sob os níveis de reação, comportamento no cargo e organizacionaL baseando-se nas teorias de Anthony Hamblin.

Adjuvant therapy with GnRH agonists/tamoxifen in breast cancer should be a good council for patients with hormone receptor-positive tumours and wish to preserve fertility

Infertility represents one of the main long-term consequences of the chemotherapy used for the adjuvant treatment of breast cancer. Approximately 60-65% of breast cancers express the nuclear hormone receptor in premenopausal women. Adjuvant endocrine therapy is an integral component of care for patients with hormone receptor-positive (HR+) tumours. The GnRH agonist (GnRHa) alone or in combination with tamoxifen produces results at least similar to those obtained with the different chemotherapy protocols in patients with HR+ breast cancer with respect to recurrence-free survival and overall survival. It is time to indicate adjuvant therapy with GnRHa associated with tamoxifen for patients with breast cancer (HR+ tumours) if they want to preserve their reproductive function. The evaluation of ovarian reserve tests: follicle stimulating hormone (FSH), anti-Mullerian hormone (AMH), inhibin B, antral follicle count (AFC) and ovarian volume 6 months, and 1 year after the end of therapy with GnRHa/tamoxifen must be realised. The recurrence-free survival and overall survival should be analysed. The major implication of this hypothesis will be to avoid adjuvant chemotherapy for patients with breast cancer (HR+ tumours) that request fertility preservation. It is expected that ovarian function should not be altered in almost all cases and subsequent pregnancy a real possibility. (C) 2012 Elsevier Ltd. All rights reserved.

Adjuvant therapy with GnRH agonists/tamoxifen in breast cancer should be a good council for patients with hormone receptor-positive tumours and wish to preserve fertility

Infertility represents one of the main long-term consequences of combination chemotherapy used for the treatment of breast cancer. Approximately 60%-65% of breast cancers express the nuclear hormone receptor in premenopausal women. Adjuvant endocrine therapy is an integral component of care for patients with hormone receptor-positive (HR+) tumours. The GnRH agonist (GnRHa) alone or in combination with tamoxifen produces results at least similar to those obtained with the different chemotherapy protocols in patients with HR+ tumors with respect to recurrence-free survival and overall survival, Presentation of the hypothesis: It is time to indicate adjuvant therapy with GnRHa associated with tamoxifen for patients with breast cancer (HR+ tumours) if they want to preserve their reproductive function. Testing the hypothesis: Assessment of ovarian reserve tests: follicle stimulating hormone (FSH), anti-Mullerian hormone (AMH), inhibin B, antral follicle count (AFC) and ovarian volume 6 months, and 1 year after the end of therapy with GnRHa/tamoxifen. The recurrence-free survival and overall survival should be analysed. Implications of the hypothesis: The major implication will be to avoid adjuvant chemotherapy for patients with breast cancer (HR+ tumours) that request fertility preservation. It is expected that ovarian function should not be altered in almost all cases. © Todos os direitos reservados a SBRA - Sociedade Brasileira de Reprodução Assistida.

Informe de relatoría: VIII Consejo Regional de Planificación = ILPES: report of the Eighth Regional Council for Planning

Contiene asistencia, organización de los trabajos y resumen de los debates centrados en la propuesta de agenda. Incluye en anexos: lista provisional de participantes, de documentos, propuesta de agenda, y resoluciones.

Nota de la Secretaría sobre la elección de nuevos miembros del Consejo Directivo del Instituto Latinoamericano de Planificación Económica y Social = Note by the Secretariat on the election of new members of the Governing Council of the Latin American Institute for Economic and Social Planning

Incluye Bibliografía

Resoluciones aprobadas por el Consejo Económico y Social (47, 48 y 49 períodos de sesiones) y por la Asamblea General (24 y 25 períodos de sesiones) = Resolutions adopted by the Economic and Social Council (47, 48 and 49 sessions) and by the General Assembly (24 and 25 session)

Incluye Bibliografía

Note by the Secretariat (Request by the Ministry of Foreign Affairs of France, on behalf of the Regional Council of Martinique for admission as an associate member of ECLAC)

Spanish version available

Report on the regional market to the session of the Inter-American Economic and Social Council: draft resolution approved by Committee I on 25 May 1957

Includes bibliography

Lista de las principales resoluciones relacionadas con la Estrategia Internacional del Desarrollo y el Programa de Acción Regional aprobadas por la Asamblea General y el Consejo Económico y Social de las NU, la CEPAL y el CDCC = List of main resolutions adopted with regard to the International Development Strategy and the Regional Programme of Action by the General Assembly, United Nations Economic and Social Council, ECLA and CDCC

Contiene el título de las resoluciones y su número.